Repligen Corp. (RGEN)
167.77
+1.25
(+0.75%)
USD |
NASDAQ |
Nov 13, 16:00
167.77
0.00 (0.00%)
After-Hours: 19:59
Repligen Price to Book Value : 4.547 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.513 |
| November 11, 2026 | 4.679 |
| November 10, 2026 | 4.715 |
| November 09, 2026 | 4.850 |
| November 06, 2026 | 4.702 |
| November 05, 2026 | 4.566 |
| November 04, 2026 | 4.830 |
| November 03, 2026 | 4.832 |
| November 02, 2026 | 4.688 |
| October 30, 2026 | 4.796 |
| October 29, 2026 | 5.113 |
| October 28, 2026 | 5.006 |
| October 27, 2026 | 4.765 |
| October 26, 2026 | 4.883 |
| October 23, 2026 | 4.795 |
| October 22, 2026 | 4.844 |
| October 21, 2026 | 4.879 |
| October 20, 2026 | 4.848 |
| October 19, 2026 | 4.782 |
| October 16, 2026 | 4.754 |
| October 15, 2026 | 4.992 |
| October 14, 2026 | 4.830 |
| October 13, 2026 | 4.754 |
| October 12, 2026 | 4.676 |
| October 09, 2026 | 4.713 |
| Date | Value |
|---|---|
| October 08, 2026 | 4.441 |
| October 07, 2026 | 4.532 |
| October 06, 2026 | 4.739 |
| October 05, 2026 | 5.136 |
| October 02, 2026 | 4.925 |
| October 01, 2026 | 4.804 |
| September 30, 2026 | 5.210 |
| September 29, 2026 | 5.198 |
| September 28, 2026 | 5.186 |
| September 25, 2026 | 5.068 |
| September 24, 2026 | 5.094 |
| September 23, 2026 | 4.930 |
| September 22, 2026 | 4.989 |
| September 21, 2026 | 4.828 |
| September 18, 2026 | 4.726 |
| September 17, 2026 | 4.761 |
| September 16, 2026 | 4.620 |
| September 15, 2026 | 4.668 |
| September 14, 2026 | 4.488 |
| September 11, 2026 | 4.413 |
| September 10, 2026 | 4.400 |
| September 09, 2026 | 4.410 |
| September 08, 2026 | 4.503 |
| September 04, 2026 | 4.478 |
| September 03, 2026 | 4.532 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 1.299 |
| Precigen, Inc. | 19.34 |
| Agilent Technologies, Inc. | 6.663 |
| Azenta, Inc. | 1.365 |
| Danaher Corp. | 3.057 |
Price to Book Value Related Metrics
| PS Ratio | 11.79 |
| Price to Free Cash Flow | 90.26 |
| Price | 167.77 |
| Earnings Yield | -0.12% |
| Market Cap | 9.511B |
| Operating PE Ratio | 136.69 |
| Normalized PE Ratio | 394.94 |